Geneva Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Geneva Advisors's MRK Position: Q2 2017 in Review
Geneva Advisors reduced its Merck (MRK) stake by 0.5% in Q2 2017, selling an estimated $384K and leaving 1,265,531 shares worth $77.4M. The position accounts for 1.33% of the portfolio, ranked #20.
Geneva Advisors first reported a position in MRK in Q2 2013 and has held it in 17 quarters since. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.
- Geneva Advisors held 1,265,531 shares of Merck worth $77.4M as of Q2 2017.
- Geneva Advisors sold 6,308 Merck shares in Q2 2017, an estimated $384K.
- Merck made up 1.33% of Geneva Advisors's portfolio in Q2 2017, its #20 holding.
- Geneva Advisors first reported a position in Merck in Q2 2013 and has held it in 17 quarters since.
- 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.